Literature DB >> 29327097

[Clinical and cognitive aspects of functional (psychogenic) tremor].

K E Zeuner1, R Schmidt2, P Schwingenschuh3.   

Abstract

Functional (psychogenic) tremor is the most common functional movement disorder. Characteristic clinical features, so called red flags, can help to make the clinical distinction of this type from other tremor disorders. The most common features include the variability of frequency and amplitude. Clinical examination should include different types of distraction including motor or cognitive tasks or testing the influence of suggestibility on tremor amplitude, frequency or direction. Patients often report sudden onset and remissions that may last for months or even years. In some cases, the tremor is only present in highly specific situations. Although functional tremor shares characteristics with voluntary actions, patients experience their abnormal movements as involuntary. Recent experimental approaches have revealed an impairment in sense of agency. The diagnosis can be supported by neurophysiological measurements including accelerometry, which achieved a sensitivity of 89.5% and a specificity of 95.9% in a validated test battery, thus providing a useful additional diagnostic tool. Psychotherapeutic treatment is indicated in patients with and without evident psychological symptoms. A specific physiotherapeutic approach for functional tremor is re-trainment.

Entities:  

Keywords:  Electrophysiology; Movement disorders; Rehabilitation; Sense of agency; Training

Mesh:

Year:  2018        PMID: 29327097     DOI: 10.1007/s00115-017-0476-y

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  29 in total

1.  Emotional stimuli and motor conversion disorder.

Authors:  Valerie Voon; Christina Brezing; Cecile Gallea; Rezvan Ameli; Karin Roelofs; W Curt LaFrance; Mark Hallett
Journal:  Brain       Date:  2010-04-05       Impact factor: 13.501

2.  Diagnostic and pathophysiological aspects of psychogenic tremors.

Authors:  G Deuschl; B Köster; C H Lücking; C Scheidt
Journal:  Mov Disord       Date:  1998-03       Impact factor: 10.338

3.  Transient arrest of psychogenic tremor induced by contralateral ballistic movements.

Authors:  Hatice Kumru; Josep Valls-Solé; Francesc Valldeoriola; Maria José Marti; Maria Teresa Sanegre; Eduardo Tolosa
Journal:  Neurosci Lett       Date:  2004-11-11       Impact factor: 3.046

4.  Physical precipitating factors in functional movement disorders.

Authors:  Isabel Pareés; Maja Kojovic; Carolina Pires; Ignacio Rubio-Agusti; Tabish A Saifee; Anna Sadnicka; Panagiotis Kassavetis; Antonella Macerollo; Kailash P Bhatia; Alan Carson; Jon Stone; Mark J Edwards
Journal:  J Neurol Sci       Date:  2014-01-08       Impact factor: 3.181

5.  Accelerometry to distinguish psychogenic from essential or parkinsonian tremor.

Authors:  K E Zeuner; R O Shoge; S R Goldstein; J M Dambrosia; M Hallett
Journal:  Neurology       Date:  2003-08-26       Impact factor: 9.910

6.  Two different pathogenetic mechanisms in psychogenic tremor.

Authors:  J Raethjen; F Kopper; R B Govindan; J Volkmann; G Deuschl
Journal:  Neurology       Date:  2004-09-14       Impact factor: 9.910

Review 7.  Psychogenic movement disorders.

Authors:  Amitabh Gupta; Anthony E Lang
Journal:  Curr Opin Neurol       Date:  2009-08       Impact factor: 5.710

Review 8.  Functional (psychogenic) movement disorders: merging mind and brain.

Authors:  Mark J Edwards; Kailash P Bhatia
Journal:  Lancet Neurol       Date:  2012-03       Impact factor: 44.182

Review 9.  Transcranial magnetic stimulation and sedation as treatment for functional neurologic disorders.

Authors:  T R J Nicholson; V Voon
Journal:  Handb Clin Neurol       Date:  2016

10.  "That pulled the rug out from under my feet!" - adverse experiences and altered emotion processing in patients with functional neurological symptoms compared to healthy comparison subjects.

Authors:  Astrid Steffen; Johanna Fiess; Roger Schmidt; Brigitte Rockstroh
Journal:  BMC Psychiatry       Date:  2015-06-24       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.